Fexinidazole was first described in 1978.[5] It was given a positive opinion by the European Medicines Agency in 2018.[2] It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.[6] Development for sleeping sickness was funded by the Drugs for Neglected Diseases initiative in collaboration with Sanofi.[7]